MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 2.003
EU - Europa 627
AS - Asia 288
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 2.928
Nazione #
US - Stati Uniti d'America 1.987
CN - Cina 168
PL - Polonia 148
IT - Italia 136
DE - Germania 97
UA - Ucraina 84
TR - Turchia 77
GB - Regno Unito 72
SE - Svezia 37
VN - Vietnam 35
FI - Finlandia 24
CA - Canada 16
BE - Belgio 15
RU - Federazione Russa 6
BR - Brasile 3
EU - Europa 3
HK - Hong Kong 3
IN - India 3
AR - Argentina 2
NL - Olanda 2
AU - Australia 1
DK - Danimarca 1
ES - Italia 1
FR - Francia 1
IE - Irlanda 1
IR - Iran 1
KW - Kuwait 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 2.928
Città #
Fairfield 264
Woodbridge 232
Ashburn 200
Ann Arbor 192
Warsaw 148
Chandler 142
Houston 142
Seattle 132
Wilmington 119
Jacksonville 113
Cambridge 92
Ferrara 77
Izmir 43
Beijing 40
Nanjing 38
Dong Ket 34
New York 29
Princeton 28
Munich 22
Shanghai 22
Boardman 20
Dearborn 20
Brussels 15
Fuzhou 15
Mcallen 14
Milan 14
Montréal 13
San Diego 11
Bologna 10
Los Angeles 10
Nanchang 10
Falls Church 7
Bremen 6
Changsha 6
Jiaxing 6
Auburn Hills 5
Shenyang 5
Addison 4
Bari 4
Cagliari 4
Helsinki 4
Jena 4
Jinan 4
Kunming 4
Mountain View 4
Redwood City 4
Augusta 3
Des Moines 3
Köln 3
London 3
Mogliano Veneto 3
Norwalk 3
San Mateo 3
Tappahannock 3
Toronto 3
Bonn 2
Ferrara di Monte Baldo 2
Guangzhou 2
Hebei 2
Hong Kong 2
Juiz De Fora 2
Philadelphia 2
Redmond 2
Tianjin 2
Washington 2
Xian 2
Zhengzhou 2
Aberdeen 1
Amsterdam 1
Ardabil 1
Bentivoglio 1
Boston 1
Bratislava 1
Buffalo 1
Chiswick 1
Dublin 1
Düsseldorf 1
Frankfurt am Main 1
Granarolo 1
Haikou 1
Hangzhou 1
Hanoi 1
Hefei 1
Hounslow 1
Islington 1
Jesi 1
Kilburn 1
Kuwait City 1
Lanzhou 1
Liberty Lake 1
Mansfield 1
Mumbai 1
Munro 1
Ningbo 1
Nole 1
Orange 1
Osimo 1
Padova 1
Portici 1
Pune 1
Totale 2.416
Nome #
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 208
null 205
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ. 153
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 129
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 128
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 128
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 126
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 124
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 120
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 118
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 117
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 114
null 110
Pharmacological characterization of tachykinin tetrabranched derivatives 107
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 106
null 105
null 103
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 99
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 97
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 94
NOP receptor pharmacological profile – A dynamic mass redistribution study 83
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 80
null 78
Pharmacological Assays for Investigating the NOP Receptor 72
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 52
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 30
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 23
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 22
Pharmacological characterization of naloxegol: In vitro and in vivo studies 21
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 18
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 14
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 14
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 7
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 1
Totale 3.006
Categoria #
all - tutte 10.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 430
Totale 11.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019241 0 0 0 0 0 0 0 0 0 0 107 134
2019/2020764 99 26 35 104 68 83 88 66 68 59 44 24
2020/2021538 37 34 30 55 16 46 18 51 29 104 66 52
2021/2022265 24 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024209 18 23 5 7 14 58 14 57 3 9 1 0
Totale 3.006